Skip to main content

Site notifications

Bausch & Lomb (Australia) Pty Ltd

Regulatory activities for this sponsor.

Sponsor content

3 result(s) found, displaying 1 to 3
  • Australian Public Assessment Report for Loteprednol etabonate
  • Regulatory action due to As the sponsor of the kind of medical device failed to comply with the notice under s.41JA of the Act, requesting the sponsor to give the TGA information relating to the kind of device, within a further 10 working days from the day specified in the notice, the entry was cancelled., effective 01/10/2013

Help us improve the Therapeutic Goods Administration site